The puzzle of depression and acute coronary syndrome: Reviewing the role of acute inflammation

Journal of Psychosomatic Research

Volumn 71, Issue 2, 2011, Pages 61-68

  Poole, Lydia ^a   Dickens, Chris ^b   Steptoe, Andrew ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Acute coronary syndrome; Depression; Inflammation; Sickness behaviour

Indexed keywords

ANTIDEPRESSANT AGENT; C REACTIVE PROTEIN; ENDOTOXIN; INTERLEUKIN 1; INTERLEUKIN 6; STATIN; TUMOR NECROSIS FACTOR; TYPHOID VACCINE;

ACUTE CORONARY SYNDROME; ANHEDONIA; BECK DEPRESSION INVENTORY; CARDIOTOXICITY; CHOLESTEROL SYNTHESIS; CORONARY ARTERY BYPASS GRAFT; DEPRESSION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FATIGUE; HEART DISEASE; HEART INFARCTION; HEART SURGERY; HOSPITAL ADMISSION; HUMAN; IMMUNOTHERAPY; INFLAMMATION; IRRITABILITY; NONHUMAN; PSYCHOTHERAPY; RECURRENCE RISK; REVIEW; TREATMENT RESPONSE;

ACUTE CORONARY SYNDROME; ANIMALS; CORONARY ARTERY BYPASS; DEPRESSIVE DISORDER; HUMANS; ILLNESS BEHAVIOR; INFLAMMATION;

EID: 79960460815     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2010.12.009     Document Type: Review

References (128)

1. Steptoe A Depression and physical illness 2007, Cambridge University Press, Cambridge.
2. Blumenthal JA Depression and coronary heart disease: association and implications for treatment. Cleve Clin J Med 2008, 75:S48.
3. Lett HS, et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 2004, 66:305-315.
4. Thombs BD, et al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 2006, 21:30-38.
5. Carney RM,, Freedland KE Depression in patients with coronary heart disease. Am J Med 2008, 121:S20-S27.
6. Frasure-Smith N, Lespérance F Depression and cardiac risk: present status and future directions. Heart 2009, 96:173-176.
7. Frasure-Smith N, Lespérance F,, Talajic M Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993, 270:1819-1825.
8. van Melle JP, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004, 66:814-822.
9. Blumenthal JA, et al. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 2003, 362:604-609.
10. Bush DE, et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 2001, 88:337-341.
11. Lespérance F, Frasure-Smith N, Talajic M, Bourassa MG Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002, 105:1049-1053.
12. Lane D, Carroll D, Ring C, Beevers DG, Lip GY Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom Med 2001, 63:221.
13. Frasure-Smith N, et al. Depression and health-care costs during the first year following myocardial infarction. J Psychosom Res 2000, 48:471-478.
14. Wellenius GA, Mukamal KJ, Kulshreshtha A, Asonganyi S, Mittleman MA Depressive symptoms and the risk of atherosclerotic progression among patients with coronary artery bypass grafts. Circulation 2008, 117:2313-2319.
15. Kurdyak PA, Gnam WH, Goering P, Chong A, Alter DA The relationship between depressive symptoms, health service consumption, and prognosis after acute myocardial infarction: a prospective cohort study. BMC Health Serv Res 2008, 8:200.
16. Lauzon C, et al. Depression and prognosis following hospital admission because of acute myocardial infarction. CMAJ 2003, 168:547-552.
17. Carney RM, Freedland KE, Miller GE, Jaffe AS Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res 2002, 53:897-902.
18. Whooley MA, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008, 300:2379-2388.
19. Nicholson A, Kuper H, Hemingway H Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006, 27:2763-2774.
20. Rieckmann N, et al. Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. Am Heart J 2006, 152:922-927.
21. Carney RM, et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 2001, 104:2024-2028.
22. Nemeroff CB, Musselman DL Are platelets the link between depression and ischemic heart disease. Am Heart J 2000, 140:57-62.
23. de Jonge P, et al. Psychophysiological biomarkers explaining the association between depression and prognosis in coronary artery patients: a critical review of the literature. Neurosci Biobehav Rev 2009, 35:84-90.
24. Grippo AJ, Johnson AK Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress 2009, 12:1-21.
25. Lippi G, Montagnana M, Favaloro EJ, Franchini M Mental depression and cardiovascular disease: a multifaceted, bidirectional association. Semin Thromb Hemost 2009, 35:325-336.
26. Mosovich SA, et al. New insights into the link between cardiovascular disease and depression. Int J Clin Pract 2008, 62:423-432.
27. Van der Kooy K, et al. Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int J Geriatr Psychiatry 2007, 22:613-626.
28. Roest AM, Martens EJ, Denollet J, de Jonge P Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med 2010, 72:563-569.
29. Dickens C, et al. New onset depression following myocardial infarction predicts cardiac mortality. Psychosom Med 2008, 70:450-455.
30. Dickens C, et al. Depression is a risk factor for mortality after myocardial infarction: fact or artifact. J Am Coll Cardiol 2007, 49:1834-1840.
31. de Jonge P, van den Brink RHS, Spijkerman TA, Ormel J Only incident depressive episodes after myocardial infarction are associated with new cardiovascular events. J Am Coll Cardiol 2006, 48:2204-2208.
32. Grace SL, et al. Effect of depression on five-year mortality after an acute coronary syndrome. Am J Cardiol 2005, 96:1179-1185.
33. Parker GB, et al. Timing is everything: the onset of depression and acute coronary syndrome outcome. Biol Psychiatry 2008, 64:660-666.
34. Carney RM, et al. History of depression and survival after acute myocardial infarction. Psychosom Med 2009, 71:253-259.
35. Lesperance F, Frasure-Smith N, Talajic M Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med 1996, 58:99-110.
36. Glassman AH, Bigger JT, Gaffney M Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch Gen Psychiatry 2009, 66:1022-1029.
37. Spijkerman T, et al. Depression following myocardial infarction: first-ever versus ongoing and recurrent episodes. Gen Hosp Psychiatry 2005, 27:411-417.
38. Goodman J, Shimbo D, Haas DC, Davidson KW, Rieckmann N Incident and recurrent major depressive disorder and coronary artery disease severity in acute coronary syndrome patients. J Psychiatr Res 2008, 42:670-675.
39. Dickens CM, et al. The risk factors for depression in first myocardial infarction patients. Psychol Med 2004, 34:1083-1092.
40. Dickens C, et al. Negative illness perceptions are associated with new-onset depression following myocardial infarction. Gen Hosp Psychiatry 2008, 30:414-420.
41. Grace SL, et al. Illness perceptions among cardiac patients: relation to depressive symptomatology and sex. J Psychosom Res 2005, 59:153-160.
42. de Jonge P, et al. Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am J Psychiatry 2006, 163:138-144.
43. Martens EJ, Hoen PW, Mittelhaeuser M, de Jonge P, Denollet J Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis. Psychol Med 2009, 1-8. 10.1017/S0033291709990997.
44. McGowan L, et al. The relationship between vital exhaustion, depression and comorbid illnesses in patients following first myocardial infarction. J Psychosom Res 2004, 57:183-188.
45. Doyle F, Conroy R, McGee H, Delaney M Depressive symptoms in persons with acute coronary syndrome: specific symptom scales and prognosis. J Psychosom Res 2010, 68:121-130.
46. Linke SE, et al. Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: a report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Arch Gen Psychiatry 2009, 66:499-507.
47. Barefoot JC, et al. Depressive symptoms and survival of patients with coronary artery disease. Psychosom Med 2000, 62:790-795.
48. Hoen PW, et al. Differential associations between specific depressive symptoms and cardiovascular prognosis in patients with stable coronary heart disease. J Am Coll Cardiol 2010, 56:838-844.
49. Davidson KW, et al. Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome. Arch Gen Psychiatry 2010, 67:480-488.
50. Leroy M, Loas G, Perez-Diaz F Anhedonia as predictor of clinical events after acute coronary syndromes: a 3-year prospective study. Compr Psychiatry 2010, 51:8-14.
51. Appels A, Höppener P, Mulder P A questionnaire to assess premonitory symptoms of myocardial infarction. Int J Cardiol 1987, 17:15-24.
52. Smith ORF, Kupper N, Denollet J, de Jonge P Vital exhaustion and cardiovascular prognosis in myocardial infarction and heart failure: predictive power of different trajectories. Psychol Med 2010, 1-8. 10.1017/S0033291710001133.
53. Kopp MS, Falger PR, Appels AD, Szedmak S Depressive symptomatology and vital exhaustion are differentially related to behavioral risk factors for coronary artery disease. Psychosom Med 1998, 60:752.
54. Berkman LF, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003, 289:3106-3116.
55. Lespérance F, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007, 297:367-379.
56. Habra ME, et al. First episode of major depressive disorder and vascular factors in coronary artery disease patients: baseline characteristics and response to antidepressant treatment in the CREATE trial. J Psychosom Res 2010, 69:133-141.
57. van Melle JP, et al. Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry 2007, 190:460-466.
58. Glassman AH, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002, 288:701-709.
59. Glassman AH, Bigger JT, Gaffney M, Shapiro PA, Swenson JR Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Arch Gen Psychiatry 2006, 63:283-288.
60. Thombs BD, et al. Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA 2008, 300:2161-2171.
61. Saab PG, et al. The impact of cognitive behavioral group training on event-free survival in patients with myocardial infarction: the ENRICHD experience. J Psychosom Res 2009, 67:45-56.
62. Carney RM, Freedland KE Treatment-resistant depression and sudden cardiac death. J Am Coll Cardiol 2009, 54:958. author reply 958-959.
63. de Jonge P, et al. Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am J Psychiatry 2007, 164:1371-1378.
64. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008, 358:252-260.
65. Eagle KA, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004, 291:2727-2733.
66. Bradshaw PJ, Ko DT, Newman AM, Donovan LR, Tu JV Validity of the GRACE (Global Registry of Acute Coronary Events) acute coronary syndrome prediction model for six month post-discharge death in an independent data set. Heart 2006, 92:905-909.
67. Tang EW, Wong C, Herbison P Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am Heart J 2007, 153:29-35.
68. Gale CP, et al. Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database. Heart 2009, 95:221-227.
69. Lett H, Ali S, Whooley M Depression and cardiac function in patients with stable coronary heart disease: findings from the Heart and Soul Study. Psychosom Med 2008, 70:444-449.
70. Kronish IM, Rieckmann N, Schwartz JE, Schwartz DR, Davidson KW Is depression after an acute coronary syndrome simply a marker of known prognostic factors for mortality?. Psychosom Med 2009, 71:697-703.
71. Alexopoulos GS, et al. Clinically defined vascular depression. Am J Psychiatry 1997, 154:562-565.
72. Rapp MA, et al. Persistent depressive symptoms after acute coronary syndrome are associated with compromised white matter integrity in the anterior cingulate: a pilot study. Psychother Psychosom 2010, 79:149-155.
73. Newson RS, et al. Atherosclerosis and incident depression in late life. Arch Gen Psychiatry 2010, 67:1144-1151.
74. Raison CL, Capuron L, Miller AH Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006, 27:24-31.
75. Howren MB, Lamkin DM, Suls J Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009, 71:171-186.
76. Stewart JC, Rand KL, Muldoon MF, Kamarck TW A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav Immun 2009, 23:936-944.
77. Gimeno D, et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med 2008, 39:413-423.
78. Reichenberg A, et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001, 58:445-452.
79. Wright CE, Strike PC, Brydon L, Steptoe A Acute inflammation and negative mood: mediation by cytokine activation. Brain Behav Immun 2005, 19:345-350.
80. Harrison NA, et al. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry 2009, 66:407-414.
81. Hingorani AD, et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 2000, 102:994-999.
82. Smeeth L, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004, 351:2611-2618.
83. Capuron L, Miller AH Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry 2004, 56:819-824.
84. Capuron L, et al. Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 2001, 26:797-808.
85. Capuron L, Ravaud A, Miller AH, Dantzer R Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy. Brain Behav Immun 2004, 18:205-213.
86. Capuron L, et al. Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am J Psychiatry 2003, 160:1342-1345.
87. Beratis S, et al. Major depression and risk of depressive symptomatology associated with short-term and low-dose interferon-alpha treatment. J Psychosom Res 2005, 58:15-18.
88. Musselman DL, et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001, 344:961-966.
89. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9:46-56.
90. Frenois F, et al. Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 2007, 32:516-531.
91. Simmons DA, Broderick PA Cytokines, stressors, and clinical depression: augmented adaptation responses underlie depression pathogenesis. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:793-807.
92. Yirmiya R Endotoxin produces a depressive-like episode in rats. Brain Res 1996, 711:163-174.
93. Yirmiya R, et al. Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology 2001, 24:531-544.
94. Merali Z, Brennan K, Brau P, Anisman H Dissociating anorexia and anhedonia elicited by interleukin-1beta: antidepressant and gender effects on responding for "free chow" and "earned" sucrose intake. Psychopharmacology (Berl) 2003, 165:413-418.
95. Bankier B, Barajas J, Martinez-Rumayor A, Januzzi JL Association between major depressive disorder and C-reactive protein levels in stable coronary heart disease patients. J Psychosom Res 2009, 66:189-194.
96. Lespérance F, Frasure-Smith N, Théroux P, Irwin M The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry 2004, 161:271-277.
97. Frasure-Smith N, et al. Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes. Biol Psychiatry 2007, 62:302-308.
98. Frasure-Smith N, Lespérance F, Irwin MR, Talajic M, Pollock BG The relationships among heart rate variability, inflammatory markers and depression in coronary heart disease patients. Brain Behav Immun 2009, 23:1140-1147.
99. Schins A, et al. Inflammatory markers in depressed post-myocardial infarction patients. J Psychiatr Res 2005, 39:137-144.
100. Empana JP, et al. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2005, 111:2299-2305.
101. Davidson KW, et al. Relation of inflammation to depression and incident coronary heart disease (from the Canadian Nova Scotia Health Survey [NSHS95] Prospective Population Study). Am J Cardiol 2009, 103:755-761.
102. Greenwood J, Mason JC Statins and the vascular endothelial inflammatory response. Trends Immunol 2007, 28:88-98.
103. Pearson TA, et al. American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation 2003, 107:645-651.
104. Hemingway H, et al. Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease. PLoS Med 2010, 7:e1000286.
105. Kushner I, Broder ML, Karp D Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest 1978, 61:235-242.
106. Suleiman M, et al. Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am J Med 2003, 115:695-701.
107. Biasucci LM, et al. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 1999, 99:2079-2084.
108. Morrow DA, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998, 31:1460-1465.
109. Kosuge M, et al. Value of serial C-reactive protein measurements in non ST-segment elevation acute coronary syndromes. Clin Cardiol 2008, 31:437-442.
110. Berton G, et al. Acute-phase inflammatory markers during myocardial infarction: association with mortality and modes of death after 7 years of follow-up. J Cardiovasc Med (Hagerstown) 2010, 11:111-117.
111. Suleiman M, et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J Am Coll Cardiol 2006, 47:962-968.
112. Yip H, et al. Level of high-sensitivity C-reactive protein is predictive of 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention. Chest 2005, 127:803-808.
113. Bursi F, et al. C-reactive protein and heart failure after myocardial infarction in the community. Am J Med 2007, 120:616-622.
114. He L, Tang X, Ling W, Chen W, Chen Y Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies. Heart 2010, 96:339-346.
115. Day JRS, Taylor KM The systemic inflammatory response syndrome and cardiopulmonary bypass. Int J Surg 2005, 3:129-140.
116. Holmes JH, et al. Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes. Inflamm Res 2002, 51:579-586.
117. Biglioli P, et al. Biological effects of off-pump vs. on-pump coronary artery surgery: focus on inflammation, hemostasis and oxidative stress. Eur J Cardiothorac Surg 2003, 24:260-269.
118. Levy JH, Tanaka KA Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003, 75:S715-S720.
119. Dantzer R, Castanon N, Lestage J, Moreau M, Capuron L Inflammation, sickness behaviour and depression. Depress Phys Illn 2006, 265-279.
120. Huijbregts KML, et al. Negative association of concomitant physical symptoms with the course of major depressive disorder: a systematic review. J Psychosom Res 2010, 68:511-519.
121. Wichers M, Maes M The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int J Neuropsychopharmacol 2002, 5:375-388.
122. Denes A, Thornton P, Rothwell NJ, Allan SM Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav Immun 2010, 24:708-723.
123. Crossman DC, et al. Investigation of the effect of interleukin-1 receptor antagonist (IL-1 ra) on markers of inflammation in non-ST elevation acute coronary syndromes (the MRC-ILA-HEART Study). Trials 2008, 9:8.
124. Lichtman JH, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 2008, 118:1768-1775.
125. Sowden G, Mastromauro CA, Januzzi JL, Fricchione GL, Huffman JC Detection of depression in cardiac inpatients: feasibility and results of systematic screening. Am Heart J 2010, 159:780-787.
126. Davidson KW, et al. Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial. Arch Intern Med 2010, 170:600-608.
127. Carney RM, et al. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA 2009, 302:1651-1657.
128. Welton NJ, Caldwell DM, Adamopoulos E, Vedhara K Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease. Am J Epidemiol 2009, 169:1158-1165.